• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙状结肠膀胱扩大术联合输尿管再植术治疗神经性膀胱

Sigmoidocolocystoplasty with ureteral reimplantation for treatment of neurogenic bladder.

机构信息

Department of Urology, China Rehabilitation Research Center, Rehabilitation College of Capital Medical University, Beijing, China.

出版信息

Urology. 2012 Aug;80(2):440-5. doi: 10.1016/j.urology.2012.05.010.

DOI:10.1016/j.urology.2012.05.010
PMID:22857763
Abstract

OBJECTIVE

To assess the clinical and urodynamic results of sigmoidocolocystoplasty in patients with neurogenic bladder dysfunction.

METHODS

We retrospectively reviewed 78 augmentation enterocystoplasty cases in our database from 2005 to 2011 to identify 47 patients who had undergone sigmoidocolocystoplasty alone or combined with ureter reimplantation. The indications for surgery and postoperative complications were evaluated. Renal function preservation, increased postoperative bladder capacity, decreased maximal detrusor pressure, and overall patient satisfaction were deemed successful outcomes.

RESULTS

The mean follow-up period was 24 months. The mean bladder capacity increased from 160.6 ± 128.3 to 468.5 ± 60.6 mL (P < .001) and the maximal detrusor pressure decreased from 31.1 ± 26.4 to 10.9 ± 4.5 cm H(2)O (P = .002). The serum creatinine level decreased from 270.3 ± 113.6 to 174.4 ± 81.3 μmol/L (P = .001). Most patients resolved the urinary incontinence using clean self-intermittent catheterization. The decrease in the mean number of incontinence episodes and pads used daily indicated a marked improvement in patients' quality of life. Postoperative complications included bowel dysfunction in 5 patients (10.6%), adhesive intestinal obstruction in 4 (8.5%), deteriorating renal function in 3 (6.4%), and vesicoureteral reflux recurrence in 2 patients (4.3%). Nearly all patients expressed satisfaction with the urologic management.

CONCLUSION

Our results suggest that sigmoidocolocystoplasty is safe and effective in treating patients with neurogenic bladder dysfunction. Concomitant ureter reimplantation will be beneficial for patients with a long history of illness.

摘要

目的

评估神经原性膀胱功能障碍患者行乙状结肠膀胱扩大术的临床和尿动力学结果。

方法

我们回顾性分析了 2005 年至 2011 年数据库中 78 例肠膀胱扩大术病例,确定了 47 例单独或联合输尿管再植术接受乙状结肠膀胱扩大术的患者。评估了手术适应证和术后并发症。保留肾功能、增加术后膀胱容量、降低最大逼尿肌压力和总体患者满意度被视为成功的结果。

结果

平均随访时间为 24 个月。膀胱容量从 160.6±128.3ml 增加到 468.5±60.6ml(P<0.001),最大逼尿肌压力从 31.1±26.4cm H2O 降低到 10.9±4.5cm H2O(P=0.002)。血清肌酐水平从 270.3±113.6μmol/L 降低到 174.4±81.3μmol/L(P=0.001)。大多数患者通过清洁间歇性自我导尿解决了尿失禁问题。失禁次数和每日使用尿垫数量的减少表明患者生活质量明显改善。术后并发症包括 5 例(10.6%)肠功能障碍、4 例(8.5%)粘连性肠梗阻、3 例(6.4%)肾功能恶化和 2 例(4.3%)膀胱输尿管反流复发。几乎所有患者对泌尿外科治疗都表示满意。

结论

我们的结果表明,乙状结肠膀胱扩大术治疗神经原性膀胱功能障碍患者是安全有效的。对于病史较长的患者,同时进行输尿管再植术将是有益的。

相似文献

1
Sigmoidocolocystoplasty with ureteral reimplantation for treatment of neurogenic bladder.乙状结肠膀胱扩大术联合输尿管再植术治疗神经性膀胱
Urology. 2012 Aug;80(2):440-5. doi: 10.1016/j.urology.2012.05.010.
2
Review of 86 patients with myelodysplasia and neurogenic bladder who underwent sigmoidocolocystoplasty and were followed more than 10 years.对86例患有骨髓发育异常和神经源性膀胱并接受乙状结肠膀胱扩大术且随访超过10年的患者进行回顾。
J Urol. 2006 Oct;176(4 Pt 2):1806-9. doi: 10.1016/j.juro.2006.03.123.
3
[Treatment of vesicoureteral reflux in patients with neurogenic bladder. Should the ureter be reimplanted in patients treated with augmentation cystoplasty?].[神经源性膀胱患者膀胱输尿管反流的治疗。接受膀胱扩大术治疗的患者是否应行输尿管再植术?]
Arch Esp Urol. 2003 Nov;56(9):1013-6.
4
Should simultaneous ureteral reimplantation be performed during sigmoid bladder augmentation to reduce vesicoureteral reflux in neurogenic bladder cases?在神经源性膀胱病例中,进行乙状结肠膀胱扩大术时是否应同时行输尿管再植术以减少膀胱输尿管反流?
Int Urol Nephrol. 2015 May;47(5):759-64. doi: 10.1007/s11255-015-0958-4. Epub 2015 Mar 31.
5
Long-term follow-up of sigmoid bladder augmentation for low-compliance neurogenic bladder.乙状结肠膀胱扩大术治疗低顺应性神经源性膀胱的长期随访
Urology. 2014 Sep;84(3):697-701. doi: 10.1016/j.urology.2014.05.025.
6
Teapot ureterocystoplasty and ureteral Mitrofanoff channel for bilateral megaureters: technical points and surgical results of neurogenic bladder.茶壶状输尿管膀胱成形术和输尿管米托法诺夫通道治疗双侧巨输尿管:神经原性膀胱的技术要点和手术结果。
J Urol. 2010 Mar;183(3):1168-74. doi: 10.1016/j.juro.2009.11.052. Epub 2010 Jan 22.
7
Sigmoidocolocystoplasty for neurogenic bladder reviewed after 20 years.20年后对用于神经源性膀胱的乙状结肠膀胱成形术的回顾。
J Pediatr Surg. 2017 Dec;52(12):2070-2073. doi: 10.1016/j.jpedsurg.2017.08.029. Epub 2017 Sep 2.
8
Bladder augmentation using the gastrointestinal tract. Indication, follow up and complications.使用胃肠道进行膀胱扩大术。适应症、随访及并发症。
Arch Esp Urol. 2011 Dec;64(10):953-9.
9
Is long-term bladder deterioration inevitable following successful isolated bladder outlet procedures in children with neuropathic bladder dysfunction?对于患有神经源性膀胱功能障碍的儿童,在成功进行孤立性膀胱出口手术后,长期膀胱恶化是否不可避免?
J Urol. 2008 May;179(5):1991-6; discussion 1996. doi: 10.1016/j.juro.2008.01.063. Epub 2008 Mar 19.
10
Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease.良性疾病患者行扩大肠膀胱成形术及可控性尿流改道术的长期随访
J Urol. 2005 May;173(5):1631-4. doi: 10.1097/01.ju.0000154891.40110.08.

引用本文的文献

1
Augmentation Uretero-enterocystoplasty Is an Effective Procedure in Protecting the Upper Urinary Tract Without Accelerating Deterioration of Renal Function.扩大性输尿管-肠膀胱成形术是一种有效保护上尿路且不会加速肾功能恶化的手术。
Eur Urol Open Sci. 2023 Mar 31;51:62-69. doi: 10.1016/j.euros.2023.03.002. eCollection 2023 May.
2
The concerns of mechanical upper urinary tract obstruction in neurogenic lower urinary tract dysfunction: Beyond augmentation cystoplasty.神经源性下尿路功能障碍中机械性上尿路梗阻的相关问题:超越膀胱扩大术。
Front Surg. 2023 Mar 23;10:1102272. doi: 10.3389/fsurg.2023.1102272. eCollection 2023.
3
The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction.
A型肉毒杆菌毒素注射疗法与扩大性输尿管-肠膀胱成形术治疗下尿路功能障碍的比较疗效
Int Neurourol J. 2023 Mar;27(1):36-46. doi: 10.5213/inj.2244220.110. Epub 2023 Mar 31.
4
[Clinical features of neurogenic bladder with vesicoureteral reflux in children].[小儿神经源性膀胱合并膀胱输尿管反流的临床特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Mar;23(3):279-282. doi: 10.7499/j.issn.1008-8830.2011131.
5
Augmentation enterocystoplasty without reimplantation for patients with neurogenic bladder and vesicoureteral reflux.无再植术的扩大肠膀胱成形术治疗神经源性膀胱和膀胱输尿管反流患者
Kaohsiung J Med Sci. 2016 Jun;32(6):323-6. doi: 10.1016/j.kjms.2016.05.003. Epub 2016 Jun 27.
6
Evaluation and Management of Neurogenic Bladder: What Is New in China?神经源性膀胱的评估与管理:中国有哪些新进展?
Int J Mol Sci. 2015 Aug 10;16(8):18580-600. doi: 10.3390/ijms160818580.
7
Electrical stimulation of somatic afferent nerves in the foot increases bladder capacity in neurogenic bladder patients after sigmoid cystoplasty.对足部躯体传入神经进行电刺激可增加乙状结肠膀胱扩大术后神经源性膀胱患者的膀胱容量。
BMC Urol. 2015 Apr 4;15:26. doi: 10.1186/s12894-015-0023-8.
8
Should simultaneous ureteral reimplantation be performed during sigmoid bladder augmentation to reduce vesicoureteral reflux in neurogenic bladder cases?在神经源性膀胱病例中,进行乙状结肠膀胱扩大术时是否应同时行输尿管再植术以减少膀胱输尿管反流?
Int Urol Nephrol. 2015 May;47(5):759-64. doi: 10.1007/s11255-015-0958-4. Epub 2015 Mar 31.
9
Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder.神经源性膀胱患者行扩大肠膀胱术对上尿路功能保护的中期结果
Int Urol Nephrol. 2014 Nov;46(11):2117-25. doi: 10.1007/s11255-014-0782-2. Epub 2014 Jul 23.
10
New grading system for upper urinary tract dilation using magnetic resonance urography in patients with neurogenic bladder.基于磁共振尿路成像的神经源性膀胱上尿路扩张新分级系统。
BMC Urol. 2014 May 22;14:38. doi: 10.1186/1471-2490-14-38.